GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Other Current Liabilities

Kineta (STU:J75) Other Current Liabilities : €0.38 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Kineta Other Current Liabilities?

Kineta's other current liabilities for the quarter that ended in Mar. 2024 was €0.38 Mil.

Kineta's quarterly other current liabilities increased from Sep. 2023 (€1.25 Mil) to Dec. 2023 (€1.33 Mil) but then declined from Dec. 2023 (€1.33 Mil) to Mar. 2024 (€0.38 Mil).

Kineta's annual other current liabilities increased from Dec. 2021 (€0.73 Mil) to Dec. 2022 (€0.77 Mil) and increased from Dec. 2022 (€0.77 Mil) to Dec. 2023 (€1.33 Mil).

Kineta Other Current Liabilities Historical Data

The historical data trend for Kineta's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kineta Other Current Liabilities Chart

Kineta Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
- - - -

Kineta Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kineta Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Kineta Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Kineta's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Kineta (STU:J75) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Other Current Liabilities
Comparable Companies
GDTC OKYO MTNB SPRB YS DYAI DTIL COYA AGLE IMUX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
KA:USA
Address
219 Terry Avenue North, Suite 300, Seattle, WA, USA, 98109
Website
https://www.kinetabio.com
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.

Kineta (STU:J75) Headlines

No Headlines